Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
MPAA Quote, Financials, Valuation and Earnings
Last price:
$11.48
Seasonality move
:
3.06%
Day range:
$11.41 - $11.68
52-week range:
$5.16 - $12.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.30x
P/B ratio:
0.87x
Volume:
189.8K
Avg. volume:
281K
1-year change:
81%
Market cap:
$224.1M
Revenue:
$757.4M
EPS (TTM):
-$1.00
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $540.8M | $650.3M | $683.1M | $717.7M | $757.4M | |
| Revenue Growth (YoY) | 0.92% | 20.25% | 5.04% | 5.07% | 5.53% | |
| Cost of Revenues | $431.3M | $532.4M | $569.1M | $585.1M | $603.5M | |
| Gross Profit | $109.5M | $117.9M | $114M | $132.6M | $153.8M | |
| Gross Profit Margin | 20.24% | 18.13% | 16.68% | 18.47% | 20.31% | |
| R&D Expenses | $8.6M | $10.5M | $10.3M | $10M | $11.4M | |
| Selling, General & Admin | $71.9M | $80.3M | $76.5M | $80.3M | $86.6M | |
| Other Inc / (Exp) | $17.6M | $1.7M | $9.3M | $4.7M | -$16M | |
| Operating Expenses | $80.4M | $90.8M | $86.8M | $90.2M | $98M | |
| Operating Income | $29M | $27M | $27.2M | $42.3M | $55.8M | |
| Net Interest Expenses | $15.8M | $15.6M | $39.6M | $60M | $55.6M | |
| EBT. Incl. Unusual Items | $30.9M | $13.1M | -$3.1M | -$13.1M | -$15.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.4M | $5.8M | $1.1M | $36.2M | $3.8M | |
| Net Income to Company | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Basic EPS (Cont. Ops) | $1.13 | $0.38 | -$0.22 | -$2.51 | -$0.99 | |
| Diluted EPS (Cont. Ops) | $1.11 | $0.38 | -$0.22 | -$2.51 | -$0.99 | |
| Weighted Average Basic Share | $19M | $19.1M | $19.3M | $19.6M | $19.7M | |
| Weighted Average Diluted Share | $19.4M | $19.6M | $19.3M | $19.6M | $19.7M | |
| EBITDA | $57.8M | $41.6M | $48.9M | $58.6M | $50.3M | |
| EBIT | $46.6M | $28.7M | $36.4M | $47M | $39.9M | |
| Revenue (Reported) | $540.8M | $650.3M | $683.1M | $717.7M | $757.4M | |
| Operating Income (Reported) | $29M | $27M | $27.2M | $42.3M | $55.8M | |
| Operating Income (Adjusted) | $46.6M | $28.7M | $36.4M | $47M | $39.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $168.1M | $163.9M | $194.7M | $189.5M | $193.1M | |
| Revenue Growth (YoY) | 11.54% | -2.51% | 18.8% | -2.7% | 1.91% | |
| Cost of Revenues | $136M | $138.1M | $158.6M | $154.7M | $154.6M | |
| Gross Profit | $32.1M | $25.8M | $36.2M | $34.8M | $38.5M | |
| Gross Profit Margin | 19.1% | 15.72% | 18.57% | 18.36% | 19.94% | |
| R&D Expenses | $2.5M | $2.9M | $2M | $2.6M | $3.5M | |
| Selling, General & Admin | $20.4M | $21.6M | $17.2M | $21.1M | $21.8M | |
| Other Inc / (Exp) | -$3.7M | $3.4M | $6.7M | $3.9M | $554K | |
| Operating Expenses | $23M | $24.5M | $19.2M | $23.7M | $25.3M | |
| Operating Income | $9.1M | $1.3M | $17M | $11.1M | $13.2M | |
| Net Interest Expenses | $3.7M | $4M | $11.9M | $14.6M | $12.5M | |
| EBT. Incl. Unusual Items | $1.8M | $680K | $11.9M | $288K | $1.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $939K | $1M | $10.4M | -$1.1M | $1.9M | |
| Net Income to Company | $835K | -$322K | $1.5M | $1.3M | -$722K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $835K | -$322K | $1.5M | $1.3M | -$722K | |
| Basic EPS (Cont. Ops) | $0.04 | -$0.02 | $0.07 | $0.07 | -$0.04 | |
| Diluted EPS (Cont. Ops) | $0.04 | -$0.02 | $0.07 | $0.03 | -$0.04 | |
| Weighted Average Basic Share | $19M | $19.1M | $19.2M | $19.7M | $19.5M | |
| Weighted Average Diluted Share | $19.5M | $19.4M | $19.2M | $19.7M | $19.5M | |
| EBITDA | $8.5M | $8M | $26.9M | $17.7M | $16.3M | |
| EBIT | $5.5M | $4.7M | $23.7M | $14.9M | $13.8M | |
| Revenue (Reported) | $168.1M | $163.9M | $194.7M | $189.5M | $193.1M | |
| Operating Income (Reported) | $9.1M | $1.3M | $17M | $11.1M | $13.2M | |
| Operating Income (Adjusted) | $5.5M | $4.7M | $23.7M | $14.9M | $13.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $540.8M | $650.3M | $683.1M | $717.7M | $757.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $431.3M | $532.4M | $569.1M | $585.1M | $603.5M | |
| Gross Profit | $109.5M | $117.9M | $114M | $132.6M | $153.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.6M | $10.5M | $10.3M | $10M | $11.4M | |
| Selling, General & Admin | $71.9M | $80.3M | $76.5M | $80.3M | $86.6M | |
| Other Inc / (Exp) | $17.6M | $1.7M | $9.3M | $4.7M | -$16M | |
| Operating Expenses | $80.4M | $90.8M | $86.8M | $90.2M | $98M | |
| Operating Income | $29M | $27M | $27.2M | $42.3M | $55.8M | |
| Net Interest Expenses | $15.8M | $15.6M | $39.6M | $60M | $55.6M | |
| EBT. Incl. Unusual Items | $30.9M | $13.1M | -$3.1M | -$13.1M | -$15.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.4M | $5.8M | $1.1M | $36.2M | $3.8M | |
| Net Income to Company | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Basic EPS (Cont. Ops) | $1.12 | $0.38 | -$0.23 | -$2.50 | -$0.99 | |
| Diluted EPS (Cont. Ops) | $1.10 | $0.37 | -$0.23 | -$2.54 | -$1.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $57.8M | $41.6M | $48.9M | $58.6M | $50.3M | |
| EBIT | $46.6M | $28.7M | $36.4M | $47M | $39.9M | |
| Revenue (Reported) | $540.8M | $650.3M | $683.1M | $717.7M | $757.4M | |
| Operating Income (Reported) | $29M | $27M | $27.2M | $42.3M | $55.8M | |
| Operating Income (Adjusted) | $46.6M | $28.7M | $36.4M | $47M | $39.9M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $650.3M | $683.1M | $717.7M | $757.4M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $532.4M | $569.1M | $585.1M | $603.5M | -- | |
| Gross Profit | $117.9M | $114M | $132.6M | $153.8M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.5M | $10.3M | $10M | $11.4M | -- | |
| Selling, General & Admin | $80.3M | $76.5M | $80.3M | $86.6M | -- | |
| Other Inc / (Exp) | $1.7M | $9.3M | $4.7M | -$16M | -- | |
| Operating Expenses | $90.8M | $86.8M | $90.2M | $98M | -- | |
| Operating Income | $27M | $27.2M | $42.3M | $55.8M | -- | |
| Net Interest Expenses | $15.6M | $39.6M | $60M | $55.6M | -- | |
| EBT. Incl. Unusual Items | $13.1M | -$3.1M | -$13.1M | -$15.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.8M | $1.1M | $36.2M | $3.8M | -- | |
| Net Income to Company | $7.4M | -$4.2M | -$49.2M | -$19.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.4M | -$4.2M | -$49.2M | -$19.5M | -- | |
| Basic EPS (Cont. Ops) | $0.38 | -$0.23 | -$2.50 | -$0.99 | -- | |
| Diluted EPS (Cont. Ops) | $0.37 | -$0.23 | -$2.54 | -$1.00 | -- | |
| Weighted Average Basic Share | $76.5M | $77.1M | $78.4M | $78.7M | -- | |
| Weighted Average Diluted Share | $78.2M | $77.2M | $78.4M | $79.4M | -- | |
| EBITDA | $41.6M | $48.9M | $58.6M | $50.3M | -- | |
| EBIT | $28.7M | $36.4M | $47M | $39.9M | -- | |
| Revenue (Reported) | $650.3M | $683.1M | $717.7M | $757.4M | -- | |
| Operating Income (Reported) | $27M | $27.2M | $42.3M | $55.8M | -- | |
| Operating Income (Adjusted) | $28.7M | $36.4M | $47M | $39.9M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.5M | $23M | $11.6M | $14M | $9.4M | |
| Short Term Investments | $1.7M | $2.2M | $2M | $1.8M | $1.9M | |
| Accounts Receivable, Net | $63.1M | $85.1M | $119.9M | $96.3M | $91.1M | |
| Inventory | $302.9M | $385.5M | $356.3M | $397.3M | $359.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.3M | $13.4M | $20.2M | $18.2M | $15.6M | |
| Total Current Assets | $422.9M | $537M | $537.5M | $560.5M | $511.5M | |
| Property Plant And Equipment | $125.4M | $133.1M | $133.7M | $122.3M | $98.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | |
| Other Intangibles | $5.3M | $3.8M | $2.1M | $1.1M | $552K | |
| Other Long-Term Assets | $1.5M | $1.4M | $1.1M | $1.7M | $3M | |
| Total Assets | $847.9M | $1B | $1B | $1B | $957.6M | |
| Accounts Payable | $129.3M | $147.5M | $119.4M | $155M | $141.9M | |
| Accrued Expenses | $54.9M | $59.1M | $60.3M | $68.5M | $64.6M | |
| Current Portion Of Long-Term Debt | $3.7M | $3.7M | $3.7M | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.4M | $6.8M | $8.8M | $8.3M | $10M | |
| Other Current Liabilities | $6.7M | $11.9M | $4.9M | $7M | $5.6M | |
| Total Current Liabilities | $326.1M | $426.4M | $382.6M | $404.4M | $351M | |
| Long-Term Debt | $16.8M | $13M | $40.3M | $30.8M | $35.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $546.7M | $700.4M | $708.1M | $726.9M | $699.9M | |
| Common Stock | $190K | $191K | $195K | $197K | $194K | |
| Other Common Equity Adj | -$7.7M | -$5.1M | -$303K | $9.2M | $3.1M | |
| Common Equity | $301.1M | $315.3M | $320.5M | $285.1M | $257.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $301.1M | $315.3M | $320.5M | $285.1M | $257.7M | |
| Total Liabilities and Equity | $847.9M | $1B | $1B | $1B | $957.6M | |
| Cash and Short Terms | $17.2M | $25.2M | $13.6M | $15.8M | $11.3M | |
| Total Debt | $104.5M | $171.7M | $189.1M | $158.8M | $126M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.5M | $23M | $11.6M | $14M | $9.4M | |
| Short Term Investments | $1.7M | $2.2M | $2M | $1.8M | $1.9M | |
| Accounts Receivable, Net | $63.1M | $85.1M | $119.9M | $96.3M | $91.1M | |
| Inventory | $302.9M | $385.5M | $356.3M | $397.3M | $359.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.3M | $13.4M | $20.2M | $18.2M | $15.6M | |
| Total Current Assets | $422.9M | $537M | $537.5M | $560.5M | $511.5M | |
| Property Plant And Equipment | $125.4M | $133.1M | $133.7M | $122.3M | $98.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | |
| Other Intangibles | $5.3M | $3.8M | $2.1M | $1.1M | $552K | |
| Other Long-Term Assets | $1.5M | $1.4M | $1.1M | $1.7M | $3M | |
| Total Assets | $847.9M | $1B | $1B | $1B | $957.6M | |
| Accounts Payable | $129.3M | $147.5M | $119.4M | $155M | $141.9M | |
| Accrued Expenses | $54.9M | $59.1M | $60.3M | $68.5M | $64.6M | |
| Current Portion Of Long-Term Debt | $3.7M | $3.7M | $3.7M | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.4M | $6.8M | $8.8M | $8.3M | $10M | |
| Other Current Liabilities | $6.7M | $11.9M | $4.9M | $7M | $5.6M | |
| Total Current Liabilities | $326.1M | $426.4M | $382.6M | $404.4M | $351M | |
| Long-Term Debt | $16.8M | $13M | $40.3M | $30.8M | $35.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $546.7M | $700.4M | $708.1M | $726.9M | $699.9M | |
| Common Stock | $190K | $191K | $195K | $197K | $194K | |
| Other Common Equity Adj | -$7.7M | -$5.1M | -$303K | $9.2M | $3.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $301.1M | $315.3M | $320.5M | $285.1M | $257.7M | |
| Total Liabilities and Equity | $847.9M | $1B | $1B | $1B | $957.6M | |
| Cash and Short Terms | $17.2M | $25.2M | $13.6M | $15.8M | $11.3M | |
| Total Debt | $104.5M | $171.7M | $189.1M | $158.8M | $126M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Depreciation & Amoritzation | $11.1M | $12.9M | $12.4M | $11.6M | $10.4M | |
| Stock-Based Compensation | $5.2M | $7.3M | $4.7M | $4.7M | $3.9M | |
| Change in Accounts Receivable | -$12.3M | -$76.5M | -$56.8M | $5M | -$26.1M | |
| Change in Inventories | -$79.1M | -$96M | $8.9M | -$57.3M | $21.3M | |
| Cash From Operations | $56.1M | -$44.9M | -$21.8M | $39.2M | $45.5M | |
| Capital Expenditures | $13.9M | $7.6M | $4.2M | $1M | $4.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.2M | -$7.9M | -$4.2M | -$479K | -$4.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $27M | $107M | $97M | $82M | $541.4M | |
| Long-Term Debt Repaid | -$101.2M | -$42.5M | -$80.9M | -$114.2M | -$580.3M | |
| Repurchase of Common Stock | -$1.1M | -$1.9M | -- | -- | -$4.8M | |
| Other Financing Activities | -$2M | -$2.9M | -$2.7M | -$4.3M | -$905K | |
| Cash From Financing | -$76.6M | $60.2M | $14.3M | -$36.4M | -$44.7M | |
| Beginning Cash (CF) | $49.6M | $15.5M | $23M | $11.6M | $14M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$34.7M | $7.4M | -$11.6M | $2.3M | -$3.6M | |
| Ending Cash (CF) | $15.5M | $23M | $11.6M | $14M | $9.4M | |
| Levered Free Cash Flow | $42.1M | -$52.4M | -$26M | $38.2M | $40.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $835K | -$322K | $1.5M | $1.3M | -$722K | |
| Depreciation & Amoritzation | $3.1M | $3.3M | $3.1M | $2.8M | $2.5M | |
| Stock-Based Compensation | $1.5M | $1.8M | $1.2M | $432K | $868K | |
| Change in Accounts Receivable | -$41.2M | -$29.9M | -$49.8M | -$13.7M | -$20.6M | |
| Change in Inventories | -$10.4M | -$30.7M | $29.8M | -$10.7M | $3.8M | |
| Cash From Operations | -$16.4M | -$22.7M | -$326K | -$9.3M | $9.1M | |
| Capital Expenditures | $1.9M | $2.4M | $594K | $538K | $2.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$2.5M | -$336K | -$59K | -$2.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $27M | $45M | $39M | $18M | $166M | |
| Long-Term Debt Repaid | -$3.6M | -$4.6M | -$38.3M | -$5.4M | -$170.4M | |
| Repurchase of Common Stock | -$1.1M | -- | -- | -- | -$2.7M | |
| Other Financing Activities | -$1.6M | -$11K | -$1.3M | -$1.4M | -$709K | |
| Cash From Financing | $21.2M | $40.4M | -$590K | $11.2M | -$7.9M | |
| Beginning Cash (CF) | $12.8M | $7.8M | $12.6M | $12.2M | $10.8M | |
| Foreign Exchange Rate Adjustment | -$130K | $2K | $269K | -$56K | $224K | |
| Additions / Reductions | $2.9M | $15.2M | -$1.3M | $1.9M | -$1.6M | |
| Ending Cash (CF) | $15.5M | $23M | $11.6M | $14M | $9.4M | |
| Levered Free Cash Flow | -$18.3M | -$25.1M | -$920K | -$9.8M | $6.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $21.5M | $7.4M | -$4.2M | -$49.2M | -$19.5M | |
| Depreciation & Amoritzation | $11.1M | $12.9M | $12.4M | $11.6M | $10.4M | |
| Stock-Based Compensation | $5.2M | $7.3M | $4.7M | $4.7M | $3.9M | |
| Change in Accounts Receivable | -$12.3M | -$76.5M | -$56.8M | $5M | -$26.1M | |
| Change in Inventories | -$79.1M | -$96M | $8.9M | -$57.3M | $21.3M | |
| Cash From Operations | $56.1M | -$44.9M | -$21.8M | $39.2M | $45.5M | |
| Capital Expenditures | $13.9M | $7.6M | $4.2M | $1M | $4.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.2M | -$7.9M | -$4.2M | -$479K | -$4.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $27M | $107M | $97M | $82M | $541.4M | |
| Long-Term Debt Repaid | -$101.2M | -$42.5M | -$80.9M | -$114.2M | -$580.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2M | -$2.9M | -$2.7M | -$4.3M | -$905K | |
| Cash From Financing | -$76.6M | $60.2M | $14.3M | -$36.4M | -$44.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$34.7M | $7.4M | -$11.6M | $2.3M | -$3.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $42.1M | -$52.4M | -$26M | $38.2M | $40.9M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.4M | -$4.2M | -$49.2M | -$19.5M | -- | |
| Depreciation & Amoritzation | $12.9M | $12.4M | $11.6M | $10.4M | -- | |
| Stock-Based Compensation | $7.3M | $4.7M | $4.7M | $3.9M | -- | |
| Change in Accounts Receivable | -$76.5M | -$56.8M | $5M | -$26.1M | -- | |
| Change in Inventories | -$96M | $8.9M | -$57.3M | $21.3M | -- | |
| Cash From Operations | -$44.9M | -$21.8M | $39.2M | $45.5M | -- | |
| Capital Expenditures | $7.6M | $4.2M | $1M | $4.6M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.9M | -$4.2M | -$479K | -$4.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $107M | $97M | $82M | $541.4M | -- | |
| Long-Term Debt Repaid | -$42.5M | -$80.9M | -$114.2M | -$580.3M | -- | |
| Repurchase of Common Stock | -$1.9M | -- | -- | -$4.8M | -- | |
| Other Financing Activities | -$2.9M | -$2.7M | -$4.3M | -$905K | -- | |
| Cash From Financing | $60.2M | $14.3M | -$36.4M | -$44.7M | -- | |
| Beginning Cash (CF) | $66.1M | $52.4M | $44.9M | $42.7M | -- | |
| Foreign Exchange Rate Adjustment | $78K | $217K | $124K | -$898K | -- | |
| Additions / Reductions | $7.4M | -$11.6M | $2.3M | -$3.6M | -- | |
| Ending Cash (CF) | $73.6M | $41M | $47.3M | $38.2M | -- | |
| Levered Free Cash Flow | -$52.4M | -$26M | $38.2M | $40.9M | -- | |
Get MPAA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MPAA
Sector
P/E ratio
--
16.92x
PEG ratio
0.00x
0.17x
P/B ratio
0.87x
1.42x
Price / LTM sales
0.30x
0.68x
Growth Metrics
MPAA
Sector
Revenue growth
1.91%
0.64%
Earnings growth
-57.14%
-1.02%
Revenue (5-year growth)
7.17%
3.61%
Earnings forecast
$0.18
$0.24
Profitability
MPAA
Sector
Profitability FY 2024
$153.8M
$456.7M
Return on invested capital
-4.68%
4.58%
Return on assets
-1.99%
2.72%
Return on equity
-7.28%
6.7%
Earnings Date
Last Earnings Date
Jun
9
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Sep
8
Balance Sheet
MPAA
Sector
Total cash
$11.3M
$139.6M
Short term investments
$1.9M
$46.8M
Total assets
$957.6M
$1.4B
Long term debt
$126M
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
